查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1660672

2025 年至 2033 年心室辅助装置市场报告（按产品、流量类型、产品类型、应用、最终用户和地区）

Ventricular Assist Devices Market Report by Product, Flow Type, Product Type, Application, End User, and Region 2025-2033
出版日期: | 出版商: IMARC | 英文 149 Pages | 商品交期: 2-3个工作天内

价格

2024IMARC Group全球心室辅助装置市场规模达到 21 亿美元。心臟衰竭盛行率不断上升、捐赠心臟数量有限、支持性监管框架和更快的审批速度、心臟辅助装置植入手术技术的改进以及技术进步是推动市场发展的一些关键因素。

心室辅助装置 (VAD) 是一种用于支持衰弱或衰竭心臟功能的医疗设备。它们主要用作患者等待心臟移植期间的临时措施或作为不符合移植条件的患者的长期解决方案。心室辅助装置 (VAD) 是透过手术植入的，有助于将血液从心室泵送到身体的其他部位。这些设备由一个通常放置在患者腹部或胸部的帮浦和一条将帮浦连接到外部电源的传动系统组成。此帮浦负责接管心臟的泵血功能，确保血液充分循环至全身。它们可以帮助缓解症状，包括疲劳、呼吸急促和体液滞留。此外，心臟辅助装置可以作为移植的桥樑，使患者保持稳定，并提高他们接受捐赠心臟的机会。因此，VAD 彻底改变了心臟衰竭的治疗方法，并提高了患者的生活品质、能量水平和存活率。

心血管疾病（CVD）盛行率的上升是推动市场成长的关键因素之一。除此之外，医疗专业人员和患者对 VAD 治疗的好处和可用性的认识不断提高，这也促进了市场的扩张。向医疗服务提供者、患者和护理人员宣传 VAD 在治疗心臟衰竭方面的有效性的力度不断加大，使得这些设备的接受度和采用率不断提高。此外，支持性监管框架和批准促进了 VAD 的商业化和采用。世界各地的监管机构一直积极参与简化审批流程、确保安全并促进 VAD 技术的创新。这种有利的监管环境鼓励製造商投资研发并推出先进的 VAD。此外，VAD植入手术技术的进步使得手术更加安全、更容易。开胸手术或肋下切口等微创（MI）手术方法的引入，减少了手术创伤，缩短了恢復时间，扩大了患者接受 VAD 治疗的资格，从而加速了 VAD 的采用。此外，医疗保健支出的增加（特别是在新兴经济体）也促进了 VAD 市场的成长。其他因素，包括显着的经济成长、不断改善的医疗保健基础设施、政府为提高医疗保健服务而采取的有利倡议以及患者对投资心臟衰竭新治疗方案的意愿不断增强，预计也将刺激市场成长。

心室辅助装置市场趋势/驱动因素：

心臟衰竭盛行率增加

全球范围内心衰竭盛行率的不断上升是推动心室辅助装置市场发展的重要因素。心臟衰竭病例的增加可归因于人口老化、个人久坐的生活方式、肥胖以及糖尿病和高血压等慢性疾病的增加。心臟衰竭的风险随着年龄的增长而增加，老年人更有可能需要机械循环支持。人口老化，尤其是已开发国家的人口老化，为 VAD 创造了大量的患者群体，从而推动了市场成长。随着心臟衰竭患者数量的不断增长，对 VAD 作为可行治疗选择的需求也在增加。 VAD 为患有晚期心臟衰竭、可能无法对常规疗法做出充分反应的患者提供了解决方案，提供了机械支持并改善了他们的生活品质。

捐献心臟数量有限

适合移植的捐赠心臟的稀缺性是推动市场成长的另一个关键因素。心臟移植仍然是末期心臟衰竭的黄金标准治疗方法。然而，可供捐赠的心臟数量远远无法满足需求。由于心臟辅助装置 (VAD) 可充当移植的桥樑，保持患者病情稳定，并提高他们接受捐赠心臟的机会，因此它们越来越多地被用作不适合移植的患者的长期解决方案。因此，合适心臟捐赠者的有限性产生了对心臟移植替代方案的需求，例如 VAD，预计这将在预测期内进一步推动市场的成长。

科技进步的崛起

VAD 技术的快速进步极大地促进了市场的成长。主要参与者的持续研究和开发 (R&D) 努力使得设备尺寸更小、耐用性更高、控制系统增强、患者治疗效果更好。这些技术进步将 VAD 的使用范围扩大到了更广泛的患者群体，包括体型较小的患者或患有心臟衰竭的儿童。此外，设备设计和植入技术的进步降低了併发症的风险，提高了设备的可靠性，并改善了患者的舒适度。 VAD 技术的创新和改进促进了更有效率、更安全、对医疗专业人员和患者都更具吸引力的创新设备的开发，从而支持了市场成长。

目录

第 1 章：前言

第 2 章：范围与方法

  • 研究目标
  • 利害关係人
  • 资料来源
    • 主要来源
    • 次要来源
  • 市场预测
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第 3 章：执行摘要

第 4 章：简介

  • 概述
  • 主要行业趋势

第 5 章：全球心室辅助装置市场

  • 市场概况
  • 市场表现
  • COVID-19 的影响
  • 市场预测

第六章：市场区隔：依产品

  • 左心室辅助装置 (LVAD)
    • 市场趋势
    • 市场预测
  • 右心室辅助装置 (RVAD)
    • 市场趋势
    • 市场预测
  • 双心室辅助装置 (BiVAD)
    • 市场趋势
    • 市场预测
  • 其他的
    • 市场趋势
    • 市场预测

第七章：市场区隔：依流量类型

  • 脉动流
    • 市场趋势
    • 市场预测
  • 非脉动或连续流
    • 市场趋势
    • 市场预测

第 8 章：市场区隔：依产品类型

  • 植入式心室辅助装置
    • 市场趋势
    • 市场预测
  • 非植入式心室辅助装置
    • 市场趋势
    • 市场预测

第 9 章：市场区隔：按应用

  • 移植前桥接 (BTT) 治疗
    • 市场趋势
    • 市场预测
  • 目的地治疗
    • 市场趋势
    • 市场预测
  • 通往復苏之桥和通往候选人之桥
    • 市场趋势
    • 市场预测

第 10 章：市场区隔：依最终用户

  • 门诊手术中心
    • 市场趋势
    • 市场预测
  • 医院
    • 市场趋势
    • 市场预测
  • 其他的
    • 市场趋势
    • 市场预测

第 11 章：市场区隔：按地区

  • 北美洲
    • 美国
    • 加拿大
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 韩国
    • 澳洲
    • 印尼
    • 其他的
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙
    • 俄罗斯
    • 其他的
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他的
  • 中东和非洲
    • 市场趋势
    • 市场区隔：依国家
    • 市场预测

第 12 章：SWOT 分析

  • 概述
  • 优势
  • 弱点
  • 机会
  • 威胁

第 13 章：价值链分析

第 14 章：波特五力分析

  • 概述
  • 买家的议价能力
  • 供应商的议价能力
  • 竞争程度
  • 新进入者的威胁
  • 替代品的威胁

第 15 章：价格指标

第 16 章：竞争格局

  • 市场结构
  • 关键参与者
  • 关键参与者简介
    • Abbott Laboratories
    • Abiomed Inc.
    • Berlin Heart GmbH (Syscore GmbH)
    • Bivacor Inc.
    • Calon Cardio
    • Cardiacassist Inc. (LivaNova PLC)
    • CHF Solutions Inc.
    • Jarvik Heart Inc.
    • MAQUET GmbH (Getinge)
    • Medtronic Inc.
    • Syncardia Systems LLC (Versa Capital Management LLC)
    • TandemLife (LivaNova Plc)
    • Terumo Corporation
Product Code: SR112025A2276

The global ventricular assist devices market size reached USD 2.1 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 4.3 Billion by 2033, exhibiting a growth rate (CAGR) of 8.06% during 2025-2033. The growing prevalence of heart failure, limited availability of donor hearts, supportive regulatory framework and faster approvals, improvements in surgical techniques for VAD implantation, and technological advancements represent some of the key factors propelling the market.

Ventricular assist devices (VADs) are medical devices designed to support the functioning of a weakened or failing heart. They are primarily used as a temporary measure while a patient awaits a heart transplant or as a long-term solution for patients who are not eligible for transplantation. VADs are implanted surgically and help pump blood from the heart's ventricles to the rest of the body. These devices consist of a pump, which is typically placed in the patient's abdomen or chest, and a driveline that connects the pump to an external power source. The pump is responsible for taking over the pumping action of the heart, ensuring that blood is adequately circulated throughout the body. They can help relieve symptoms, including fatigue, shortness of breath, and fluid retention. Moreover, VADs can serve as a bridge to transplantation, keeping patients stable and improving their chances of receiving a donor heart. As a result, VADs have revolutionized the treatment of heart failure, providing patients with improved quality of life, higher energy levels, and increased survival rates.

A rise in the prevalence of cardiovascular diseases (CVDs) represents one of the key factors driving market growth. Besides this, the growing awareness among healthcare professionals and patients about the benefits and availability of VAD therapy is contributing to the market expansion. A surge in efforts to educate healthcare providers, patients, and caregivers about the effectiveness of VADs in managing heart failure has led to increased acceptance and adoption of these devices. In addition, supportive regulatory frameworks and approvals have facilitated the commercialization and adoption of VADs. Regulatory agencies worldwide have been actively involved in streamlining the approval process, ensuring safety, and promoting innovation in VAD technology. Such favorable regulatory environments encourage manufacturers to invest in research and development (R&D) and introduce advanced VADs. Additionally, advancements in surgical techniques for VAD implantation have made the procedure safer and more accessible. The introduction of minimally invasive (MI) surgical approaches, such as thoracotomy or subcostal incisions, has reduced surgical trauma, shortened recovery times, and expanded the eligibility of patients for VAD therapy, which in turn has accelerated the adoption of VADs. Furthermore, the increasing healthcare expenditure, particularly in emerging economies, is contributing to the growth of the VADs market. Other factors, including significant economic growth, improving healthcare infrastructure, favorable government initiatives to enhance healthcare access, and the rising willingness of patients to invest in novel treatment options for heart failure, are also anticipated to stimulate market growth.

Ventricular Assist Devices Market Trends/Drivers:

Increase in the prevalence of heart failure

The growing prevalence of heart failure across the globe is a significant factor driving the market for ventricular assist devices. The rise in heart failure cases can be attributed to the aging population, sedentary lifestyles of individuals, obesity, and an increase in chronic diseases such as diabetes and hypertension. The risk of heart failure rises with age, and older adults are more likely to require mechanical circulatory support. The aging population, especially in developed countries, creates a substantial patient pool for VADs, fueling market growth. As the number of heart failure patients continues to grow, the demand for VADs as a viable treatment option also increases. VADs offer a solution for individuals with advanced heart failure who may not respond adequately to conventional therapies, providing mechanical support and improving their quality of life.

Limited availability of donor hearts

The scarcity of suitable donor hearts for transplantation is another critical factor strengthening the market growth. Heart transplantation remains the gold standard treatment for end-stage heart failure. However, the number of available donor hearts falls significantly short of the demand. Since VADs serve as a bridge to transplantation, keeping patients stable and improving their chances of receiving a donor heart, they are increasingly being used as a long-term solution for patients who are not eligible for transplantation. As a result, the limited availability of suitable heart donors has generated the need for alternatives to heart transplantation, such as VADs, which is further expected to fuel the growth of the market during the forecast period.

Rise in technological advancements

Rapid advancements in VAD technology have significantly contributed to the growth of the market. Continuous research and development (R&D) efforts by key players have led to smaller device sizes, improved durability, enhanced control systems, and better patient outcomes. These technological advancements have expanded the use of VADs to a broader patient population, including those with smaller body sizes or children with heart failure. Moreover, advancements in device design and implantation techniques have reduced the risk of complications, increased device reliability, and improved patient comfort. Such innovations and improvements in VAD technology have led to the development of innovative devices that are more efficient, safer, and appealing to both healthcare professionals and patients, thereby supporting market growth.

Ventricular Assist Devices Industry Segmentation:

Breakup by Product:

  • Left Ventricular Assist Device (LVAD)
  • Right Ventricular Assist Device (RVAD)
  • Biventricular Assist Device (BiVAD)
  • Others

Left ventricular assist device (LVAD) represents the most popular product

Breakup by Flow Type:

  • Pulsatile Flow
  • Non-Pulsatile or Continuous Flow

Non-pulsatile or continuous flow dominates the market

Breakup by Product Type:

  • Implantable Ventricular Assist Devices
  • Non-implantable Ventricular Assist Devices

Implantable ventricular assist devices represent the largest product type

Breakup by Application:

  • Bridge-to-Transplant (BTT) Therapy
  • Destination Therapy
  • Bridge to Recovery and Bridge to Candidacy

Bridge-to-transplant (BTT) therapy accounts for the majority of the market share

Breakup by End User:

  • Ambulatory Surgery Centers
  • Hospital
  • Others

Hospital holds the leading position in the market

Breakup by Region:

  • North America
  • United States
  • Canada
  • Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
  • Latin America
  • Brazil
  • Mexico
  • Others
  • Middle East and Africa

North America exhibits a clear dominance in the market

The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America was the largest market for ventricular assist devices.

The report has provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major companies have also been provided. Some of the key players in the market include:

  • Abbott Laboratories
  • Abiomed Inc.
  • Berlin Heart GmbH (Syscore GmbH)
  • Bivacor Inc.
  • Calon Cardio
  • Cardiacassist Inc. (LivaNova PLC)
  • CHF Solutions Inc.
  • Jarvik Heart Inc.
  • MAQUET GmbH (Getinge)
  • Medtronic Inc.
  • Syncardia Systems LLC (Versa Capital Management LLC)
  • TandemLife (LivaNova PLC)
  • Terumo Corporation

Key Questions Answered in This Report

  • 1.How big is the global ventricular assist devices market?
  • 2.What is the expected growth rate of the global ventricular assist devices market during 2025-2033?
  • 3.What are the key factors driving the global ventricular assist devices market?
  • 4.What has been the impact of COVID-19 on the global ventricular assist devices market?
  • 5.What is the breakup of the global ventricular assist devices market based on the product?
  • 6.What is the breakup of the global ventricular assist devices market based on the flow type?
  • 7.What is the breakup of the global ventricular assist devices market based on the product type?
  • 8.What is the breakup of the global ventricular assist devices market based on the application?
  • 9.What is the breakup of the global ventricular assist devices market based on the end-user?
  • 10.What are the key regions in the global ventricular assist devices market?
  • 11.Who are the key players/companies in the global ventricular assist devices market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Ventricular Assist Device Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product

  • 6.1 Left Ventricular Assist Device (LVAD)
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Right Ventricular Assist Device (RVAD)
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Biventricular Assist Device (BiVAD)
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Others
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast

7 Market Breakup by Flow Type

  • 7.1 Pulsatile Flow
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Non-Pulsatile or Continuous Flow
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast

8 Market Breakup by Product Type

  • 8.1 Implantable Ventricular Assist Devices
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Non-implantable Ventricular Assist Devices
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast

9 Market Breakup by Application

  • 9.1 Bridge-to-Transplant (BTT) Therapy
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Destination Therapy
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Bridge to Recovery and Bridge to Candidacy
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast

10 Market Breakup by End-User

  • 10.1 Ambulatory Surgery Centers
    • 10.1.1 Market Trends
    • 10.1.2 Market Forecast
  • 10.2 Hospitals
    • 10.2.1 Market Trends
    • 10.2.2 Market Forecast
  • 10.3 Others
    • 10.3.1 Market Trends
    • 10.3.2 Market Forecast

11 Market Breakup by Region

  • 11.1 North America
    • 11.1.1 United States
      • 11.1.1.1 Market Trends
      • 11.1.1.2 Market Forecast
    • 11.1.2 Canada
      • 11.1.2.1 Market Trends
      • 11.1.2.2 Market Forecast
  • 11.2 Asia Pacific
    • 11.2.1 China
      • 11.2.1.1 Market Trends
      • 11.2.1.2 Market Forecast
    • 11.2.2 Japan
      • 11.2.2.1 Market Trends
      • 11.2.2.2 Market Forecast
    • 11.2.3 India
      • 11.2.3.1 Market Trends
      • 11.2.3.2 Market Forecast
    • 11.2.4 South Korea
      • 11.2.4.1 Market Trends
      • 11.2.4.2 Market Forecast
    • 11.2.5 Australia
      • 11.2.5.1 Market Trends
      • 11.2.5.2 Market Forecast
    • 11.2.6 Indonesia
      • 11.2.6.1 Market Trends
      • 11.2.6.2 Market Forecast
    • 11.2.7 Others
      • 11.2.7.1 Market Trends
      • 11.2.7.2 Market Forecast
  • 11.3 Europe
    • 11.3.1 Germany
      • 11.3.1.1 Market Trends
      • 11.3.1.2 Market Forecast
    • 11.3.2 France
      • 11.3.2.1 Market Trends
      • 11.3.2.2 Market Forecast
    • 11.3.3 United Kingdom
      • 11.3.3.1 Market Trends
      • 11.3.3.2 Market Forecast
    • 11.3.4 Italy
      • 11.3.4.1 Market Trends
      • 11.3.4.2 Market Forecast
    • 11.3.5 Spain
      • 11.3.5.1 Market Trends
      • 11.3.5.2 Market Forecast
    • 11.3.6 Russia
      • 11.3.6.1 Market Trends
      • 11.3.6.2 Market Forecast
    • 11.3.7 Others
      • 11.3.7.1 Market Trends
      • 11.3.7.2 Market Forecast
  • 11.4 Latin America
    • 11.4.1 Brazil
      • 11.4.1.1 Market Trends
      • 11.4.1.2 Market Forecast
    • 11.4.2 Mexico
      • 11.4.2.1 Market Trends
      • 11.4.2.2 Market Forecast
    • 11.4.3 Others
      • 11.4.3.1 Market Trends
      • 11.4.3.2 Market Forecast
  • 11.5 Middle East and Africa
    • 11.5.1 Market Trends
    • 11.5.2 Market Breakup by Country
    • 11.5.3 Market Forecast

12 SWOT Analysis

  • 12.1 Overview
  • 12.2 Strengths
  • 12.3 Weaknesses
  • 12.4 Opportunities
  • 12.5 Threats

13 Value Chain Analysis

14 Porters Five Forces Analysis

  • 14.1 Overview
  • 14.2 Bargaining Power of Buyers
  • 14.3 Bargaining Power of Suppliers
  • 14.4 Degree of Competition
  • 14.5 Threat of New Entrants
  • 14.6 Threat of Substitutes

15 Price Indicators

16 Competitive Landscape

  • 16.1 Market Structure
  • 16.2 Key Players
  • 16.3 Profiles of Key Players
    • 16.3.1 Abbott Laboratories
      • 16.3.1.1 Company Overview
      • 16.3.1.2 Product Portfolio
      • 16.3.1.3 Financials
      • 16.3.1.4 SWOT Analysis
    • 16.3.2 Abiomed Inc.
      • 16.3.2.1 Company Overview
      • 16.3.2.2 Product Portfolio
      • 16.3.2.3 Financials
      • 16.3.2.4 SWOT Analysis
    • 16.3.3 Berlin Heart GmbH (Syscore GmbH)
      • 16.3.3.1 Company Overview
      • 16.3.3.2 Product Portfolio
      • 16.3.3.3 Financials
    • 16.3.4 Bivacor Inc.
      • 16.3.4.1 Company Overview
      • 16.3.4.2 Product Portfolio
    • 16.3.5 Calon Cardio
      • 16.3.5.1 Company Overview
      • 16.3.5.2 Product Portfolio
      • 16.3.5.3 Financials
    • 16.3.6 Cardiacassist Inc. (LivaNova PLC)
      • 16.3.6.1 Company Overview
      • 16.3.6.2 Product Portfolio
    • 16.3.7 CHF Solutions Inc.
      • 16.3.7.1 Company Overview
      • 16.3.7.2 Product Portfolio
      • 16.3.7.3 Financials
    • 16.3.8 Jarvik Heart Inc.
      • 16.3.8.1 Company Overview
      • 16.3.8.2 Product Portfolio
    • 16.3.9 MAQUET GmbH (Getinge)
      • 16.3.9.1 Company Overview
      • 16.3.9.2 Product Portfolio
      • 16.3.9.3 Financials
      • 16.3.9.4 SWOT Analysis
    • 16.3.10 Medtronic Inc.
      • 16.3.10.1 Company Overview
      • 16.3.10.2 Product Portfolio
    • 16.3.11 Syncardia Systems LLC (Versa Capital Management LLC)
      • 16.3.11.1 Company Overview
      • 16.3.11.2 Product Portfolio
      • 16.3.11.3 SWOT Analysis
    • 16.3.12 TandemLife (LivaNova Plc)
      • 16.3.12.1 Company Overview
      • 16.3.12.2 Product Portfolio
    • 16.3.13 Terumo Corporation
      • 16.3.13.1 Company Overview
      • 16.3.13.2 Product Portfolio
      • 16.3.13.3 Financials
      • 16.3.13.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Ventricular Assist Device Market: Major Drivers and Challenges
  • Figure 2: Global: Ventricular Assist Device Market: Sales Value (in Billion USD), 2019-2024
  • Figure 3: Global: Ventricular Assist Device Market: Breakup by Product (in %), 2024
  • Figure 4: Global: Ventricular Assist Device Market: Breakup by Flow Type (in %), 2024
  • Figure 5: Global: Ventricular Assist Device Market: Breakup by Product Type (in %), 2024
  • Figure 6: Global: Ventricular Assist Device Market: Breakup by Application (in %), 2024
  • Figure 7: Global: Ventricular Assist Device Market: Breakup by End-User (in %), 2024
  • Figure 8: Global: Ventricular Assist Device Market: Breakup by Region (in %), 2024
  • Figure 9: Global: Ventricular Assist Device Market Forecast: Sales Value (in Billion USD), 2025-2033
  • Figure 10: Global: Ventricular Assist Device (Left Ventricular Assist Device) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 11: Global: Ventricular Assist Device (Left Ventricular Assist Device) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 12: Global: Ventricular Assist Device (Right Ventricular Assist Device) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 13: Global: Ventricular Assist Device (Right Ventricular Assist Device) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 14: Global: Ventricular Assist Device (Biventricular Assist Device) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 15: Global: Ventricular Assist Device (Biventricular Assist Device) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 16: Global: Ventricular Assist Device (Other Products) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 17: Global: Ventricular Assist Device (Other Products) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 18: Global: Ventricular Assist Device (Pulsatile Flow) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 19: Global: Ventricular Assist Device (Pulsatile Flow) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 20: Global: Ventricular Assist Device (Non-Pulsatile or Continuous Flow) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 21: Global: Ventricular Assist Device (Non-Pulsatile or Continuous Flow) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 22: Global: Ventricular Assist Device (Implantable Ventricular Assist Devices) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 23: Global: Ventricular Assist Device (Implantable Ventricular Assist Devices) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 24: Global: Ventricular Assist Device (Non-implantable Ventricular Assist Devices) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 25: Global: Ventricular Assist Device (Non-implantable Ventricular Assist Devices) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 26: Global: Ventricular Assist Device (Bridge-to-Transplant Therapy) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 27: Global: Ventricular Assist Device (Bridge-to-Transplant Therapy) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 28: Global: Ventricular Assist Device (Destination Therapy) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 29: Global: Ventricular Assist Device (Destination Therapy) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 30: Global: Ventricular Assist Device (Bridge to Recovery and Bridge to Candidacy) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 31: Global: Ventricular Assist Device (Bridge to Recovery and Bridge to Candidacy) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 32: Global: Ventricular Assist Device (Ambulatory Surgery Centers) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 33: Global: Ventricular Assist Device (Ambulatory Surgery Centers) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 34: Global: Ventricular Assist Device (Hospitals) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 35: Global: Ventricular Assist Device (Hospitals) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 36: Global: Ventricular Assist Device (Other End-Users) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 37: Global: Ventricular Assist Device (Other End-Users) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 38: North America: Ventricular Assist Device Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 39: North America: Ventricular Assist Device Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 40: United States: Ventricular Assist Device Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 41: United States: Ventricular Assist Device Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 42: Canada: Ventricular Assist Device Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 43: Canada: Ventricular Assist Device Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 44: Asia Pacific: Ventricular Assist Device Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 45: Asia Pacific: Ventricular Assist Device Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 46: China: Ventricular Assist Device Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 47: China: Ventricular Assist Device Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 48: Japan: Ventricular Assist Device Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 49: Japan: Ventricular Assist Device Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 50: India: Ventricular Assist Device Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 51: India: Ventricular Assist Device Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 52: South Korea: Ventricular Assist Device Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 53: South Korea: Ventricular Assist Device Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 54: Australia: Ventricular Assist Device Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 55: Australia: Ventricular Assist Device Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 56: Indonesia: Ventricular Assist Device Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 57: Indonesia: Ventricular Assist Device Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 58: Others: Ventricular Assist Device Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 59: Others: Ventricular Assist Device Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 60: Europe: Ventricular Assist Device Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 61: Europe: Ventricular Assist Device Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 62: Germany: Ventricular Assist Device Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 63: Germany: Ventricular Assist Device Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 64: France: Ventricular Assist Device Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 65: France: Ventricular Assist Device Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 66: United Kingdom: Ventricular Assist Device Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 67: United Kingdom: Ventricular Assist Device Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 68: Italy: Ventricular Assist Device Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 69: Italy: Ventricular Assist Device Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 70: Spain: Ventricular Assist Device Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 71: Spain: Ventricular Assist Device Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 72: Russia: Ventricular Assist Device Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 73: Russia: Ventricular Assist Device Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 74: Others: Ventricular Assist Device Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 75: Others: Ventricular Assist Device Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 76: Latin America: Ventricular Assist Device Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 77: Latin America: Ventricular Assist Device Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 78: Brazil: Ventricular Assist Device Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 79: Brazil: Ventricular Assist Device Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 80: Mexico: Ventricular Assist Device Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 81: Mexico: Ventricular Assist Device Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 82: Others: Ventricular Assist Device Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 83: Others: Ventricular Assist Device Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 84: Middle East and Africa: Ventricular Assist Device Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 85: Middle East and Africa: Ventricular Assist Device Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 86: Global: Ventricular Assist Device Industry: SWOT Analysis
  • Figure 87: Global: Ventricular Assist Device Industry: Value Chain Analysis
  • Figure 88: Global: Ventricular Assist Device Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Ventricular Assist Device Market: Key Industry Highlights, 2024 and 2033
  • Table 2: Global: Ventricular Assist Device Market Forecast: Breakup by Product (in Million USD), 2025-2033
  • Table 3: Global: Ventricular Assist Device Market Forecast: Breakup by Flow Type (in Million USD), 2025-2033
  • Table 4: Global: Ventricular Assist Device Market Forecast: Breakup by Product Type (in Million USD), 2025-2033
  • Table 5: Global: Ventricular Assist Device Market Forecast: Breakup by Application (in Million USD), 2025-2033
  • Table 6: Global: Ventricular Assist Device Market Forecast: Breakup by End-User (in Million USD), 2025-2033
  • Table 7: Global: Ventricular Assist Device Market Forecast: Breakup by Region (in Million USD), 2025-2033
  • Table 8: Global: Ventricular Assist Device Market Structure
  • Table 9: Global: Ventricular Assist Device Market: Key Players